Status:
COMPLETED
Comparing Efficacy of Optimal Treatment and Conventional Treatment for Major Depressive Disorder in Viet Nam
Lead Sponsor:
University of Medicine and Pharmacy at Ho Chi Minh City
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Comparison of efficacy treatment (respond, remission) between the optimized treatment group (dose adjustment or early change other drug based on the change of total score HAM-D 17) and the routine tre...
Detailed Description
Major depressive disorder (MDD) is a common with a lifetime prevalence about 16 %. MDD is able to be a recurrent and chronic condition. MDD is the second leading cause of disability worldwide. This di...
Eligibility Criteria
Inclusion
- New or first recurrent diagnosed as major depression disorder.
- Having total score HAM-D 17 ≥ 17 point
Exclusion
- Can not answer the question in HAM-D 17
- Having psychosis, anxiety disorder, obsessive-compulsive disorder
- Having risk of suicide now or 3 months past
- having medical history: diabetes mellitus, hypothyroidism, hypopituitarism, epilepsy, renal failure, heart failure, stroke, myocardial infarction, liver failure, cirrhosis.
- Pregnancy
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2023
Estimated Enrollment :
171 Patients enrolled
Trial Details
Trial ID
NCT04826614
Start Date
March 1 2021
End Date
July 30 2023
Last Update
August 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center
Ho Chi Minh City, Vietnam